Article Type
Changed
Thu, 12/15/2022 - 15:00
Display Headline
Prostate Cancer in Male Seniors, Part 2: Treatment
Treatment decisions for patients with prostate cancer should be based on a patient’s health status, including life expectancy, functional performance, and comorbidities.

This article (part 2 of 2) focuses on the treatment of prostate cancer in seniors. Part 1 provided an overview of prostate cancer epidemiology, pathology, and screening in senior patients.

There have been no specific practice guidelines for managing prostate cancer in older adults, and the current management of older patients with prostate cancer is often suboptimal. Recently, the International Society of Geriatric Oncology assembled a multidisciplinary prostate cancer working group, which has begun offering guidelines on evidence-based treatments of prostate cancer in the geriatric population.

Click here to continue reading.

References

Note: Page numbers differ between the print issue and digital edition.

Author and Disclosure Information

Hong W. Chin, MD, PhD; Jyung Kim, MD; Gregory Rasp, MD; and Boris Hristov, MD

Publications
Topics
Page Number
36S-40S
Legacy Keywords
prostate cancer, incidental prostate cancer, modified Gleason Scoring System, prostate-specific antigen, PSA, prostate screening recommendations for seniors, elderly prostate cancer patients, Hong W Chin, Jyung Kim, Gregory Rasp, Boris Hristov
Sections
Author and Disclosure Information

Hong W. Chin, MD, PhD; Jyung Kim, MD; Gregory Rasp, MD; and Boris Hristov, MD

Author and Disclosure Information

Hong W. Chin, MD, PhD; Jyung Kim, MD; Gregory Rasp, MD; and Boris Hristov, MD

Treatment decisions for patients with prostate cancer should be based on a patient’s health status, including life expectancy, functional performance, and comorbidities.
Treatment decisions for patients with prostate cancer should be based on a patient’s health status, including life expectancy, functional performance, and comorbidities.

This article (part 2 of 2) focuses on the treatment of prostate cancer in seniors. Part 1 provided an overview of prostate cancer epidemiology, pathology, and screening in senior patients.

There have been no specific practice guidelines for managing prostate cancer in older adults, and the current management of older patients with prostate cancer is often suboptimal. Recently, the International Society of Geriatric Oncology assembled a multidisciplinary prostate cancer working group, which has begun offering guidelines on evidence-based treatments of prostate cancer in the geriatric population.

Click here to continue reading.

This article (part 2 of 2) focuses on the treatment of prostate cancer in seniors. Part 1 provided an overview of prostate cancer epidemiology, pathology, and screening in senior patients.

There have been no specific practice guidelines for managing prostate cancer in older adults, and the current management of older patients with prostate cancer is often suboptimal. Recently, the International Society of Geriatric Oncology assembled a multidisciplinary prostate cancer working group, which has begun offering guidelines on evidence-based treatments of prostate cancer in the geriatric population.

Click here to continue reading.

References

Note: Page numbers differ between the print issue and digital edition.

References

Note: Page numbers differ between the print issue and digital edition.

Page Number
36S-40S
Page Number
36S-40S
Publications
Publications
Topics
Article Type
Display Headline
Prostate Cancer in Male Seniors, Part 2: Treatment
Display Headline
Prostate Cancer in Male Seniors, Part 2: Treatment
Legacy Keywords
prostate cancer, incidental prostate cancer, modified Gleason Scoring System, prostate-specific antigen, PSA, prostate screening recommendations for seniors, elderly prostate cancer patients, Hong W Chin, Jyung Kim, Gregory Rasp, Boris Hristov
Legacy Keywords
prostate cancer, incidental prostate cancer, modified Gleason Scoring System, prostate-specific antigen, PSA, prostate screening recommendations for seniors, elderly prostate cancer patients, Hong W Chin, Jyung Kim, Gregory Rasp, Boris Hristov
Sections
Article Source

PURLs Copyright

Inside the Article